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cell lines, primary tissue and animal models. While these 
models have proven to be useful, poor cell phenotype, tis-
sue scarcity, batch-to-batch variation and species differences 
have led to difficulties in data extrapolation toward human 
development. Therefore, in this study we have employed 
hepatoblasts, derived from pluripotent stem cells, to model 
the effects of xenobiotics from cigarette smoke on human 
hepatocyte development. Highly pure hepatocyte popula-
tions (>90%) were produced in vitro and exposed to factors 
present in cigarette smoke. Analysis of ATP levels revealed 
that, independent of the sex, the majority of smoking deriva-
tives tested individually did not deplete ATP levels below 
50%. However, following exposure to a cocktail of smok-
ing derivatives, ATP production fell below 50% in a sex-
dependent manner. This was paralleled by a loss metabolic 
activity and secretory ability in both female and male hepat-
ocytes. Interestingly, cell depletion was less pronounced in 
female hepatocytes, whereas caspase activation was ~two-
fold greater, indicating sex differences in cell death upon 
exposure to the smoking derivatives tested.
Keywords Maternal smoking · Human development · 
Pluripotent stem cells · Hepatocytes · Apoptosis · Necrosis
Introduction
The liver is the body’s second largest organ playing a 
major role in the processing of xenotoxicants, which 
include alcohol, drugs and environmental pollutants. 
Cigarettes are an example of a widely used drug which 
can cause major health problems for adults, and consti-
tute a particular risk to the developing foetus. Cigarettes 
contain a complex mixture of over 7000 different com-
pounds (Rodgman et al. 2009) which include nicotine 
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and the polycyclic aromatic hydrocarbons (PAHs). Nico-
tine is primarily metabolised by cytochrome P450 2A6 
(CYP2A6) in the liver (Benowitz et al. 1994) into several 
metabolites, of which cotinine represents approximately 
70–80% (Messina et al. 1997). PAHs are incomplete 
combustion products first identified as carcinogenic con-
stituents of coal tar (Phillips 1983) and charcoal-grilled 
foods (Phillips 1999; Boström et al. 2002; Rodgman 
et al. 2009). PAHs are also detected in placental tissues 
and umbilical cord blood of smokers (Perera et al. 2005a; 
Al-Saleh et al. 2013) reaching the foetal liver from the 
maternal circulation. This exposes the developing foetus 
to harmful agents and leads to corresponding changes in 
gene expression (O’Shaughnessy et al. 2011).
In addition to toxicant exposure, smoking also dis-
rupts foetal oxygen and carbon monoxide balance which 
can cause harmful effects, including impaired growth, 
premature birth, hormonal imbalances, increased predis-
position to metabolic syndrome, liver disease and even 
death (Chen et al. 2006; Harvey et al. 2007; Rogers 2009; 
Mamsen et al. 2010; Fowler et al. 2011, 2014; Hackshaw 
et al. 2011; Högberg et al. 2012; Behl et al. 2013; Filis 
et al. 2015). Moreover, it has been reported that mater-
nal smoking affects the foetus in a sex-specific manner. 
For example, male offspring possess a higher risk of 
developing conduct disorders, whereas female offspring 
are predisposed to developing weight disorders and drug 
dependence (Weissman et al. 1999; Chen et al. 2006). 
In addition, maternal smoking induces sex-dependant 
molecular responses in the reproductive organs and 
the liver of the developing foetus (Fowler et al. 2008; 
O’Shaughnessy et al. 2011; Drake et al. 2015).
To date, the effect of maternal smoking on the foe-
tal liver has been studied in vitro using cell lines, pri-
mary tissue and animal models (Neumann 1986; Rao 
et al. 1988; Cho et al. 2006, Choi et al. 2015; Baxter 
2009; Sanchez et al. 2011; Van Kesteren et al. 2013; 
Williams et al. 2014). While these models have proven 
to be informative, the scarcity of human tissue, the 
rapid loss of cell phenotype, batch-to-batch variation 
and species differences have led to difficulties in data 
extrapolation toward the human. Moreover, the mature 
nature of primary cells used in vitro impairs the study 
of foetal development ‘in the dish’. In contrast to the 
above sources, human hepatocytes derived from pluri-
potent stem cells have been proven to represent a reli-
able human model to study liver biology in detail 
(Szkolnicka et al. 2014, 2016; Villarin et al. 2015). To 
study the disruptive effects of smoking on human devel-
opment, we have employed this renewable cell model. 
Pluripotent stem cell derived hepatoblasts were pro-
duced at scale from male and female cell lines. Follow-
ing this, hepatocyte differentiation was performed in the 
presence of cotinine and PAHs and this led to sex-spe-
cific changes in cell biology.
Methods and materials
Cell culture and differentiation
H9 and Man12 human embryonic stem cells (hESCs) 
identity was confirmed using short tandem repeat typ-
ing. hESCs were cultured and differentiated as previously 
described (Cameron et al. 2015). Maintenance of hESCs 
was performed on pre-coated laminin 521 (Biolaminin) 
in mTeSR1 (STEMCELL Technologies) in a humidified 
37 °C, 5%  CO2 incubator. For differentiation, hESCs 
were plated onto a pre-coated blend of laminins 521 
and 111 (at a 1:3 ratio). Differentiation was initiated at 
40% confluence by replacing serum-free medium with 
endoderm differentiation medium: RPMI 1640 contain-
ing 1× B27 (Life Technologies), 100 ng/mL Activin 
A (PeproTech), and 50 ng/mL Wnt3a (R&D Systems). 
The medium was changed every 24 h for 72 h. On day 
3, endoderm differentiation medium was replaced with 
hepatoblast differentiation medium, and this was renewed 
every second day for a further 5 days. The medium con-
sisted of knockout (KO)-DMEM (Life Technologies), 
Serum replacement (Life Technologies), 0.5% Glutamax 
(Life Technologies), 1% non-essential amino acids (Life 
Technologies), 0.2% β-mercaptoethanol (Life Technolo-
gies), and 1% DMSO (Sigma). On day 8, differentiating 
cells were cultured in the hepatocyte maturation medium 
HepatoZYME (Life Technologies) containing 1% Glu-
tamax (Life Technologies), supplemented with 10 ng/
mL hepatocyte growth factor (PeproTech) and 20 ng/mL 
oncostatin M (PeproTech). On day 10 maturation medium 
was replaced with HepatoZYME supplemented with and 
without smoking derivatives (Sigma-Aldrich) for a fur-
ther 8 days, with media replaced every 48 h.
Immunofluorescence
Cell cultures were fixed in 100% ice-cold methanol 
at −20 °C for 30 min. Subsequently, fixed cells were 
washed twice with PBS at room temperature. Cell mon-
olayers were blocked with 0.1% PBS-Tween containing 
10% BSA for 1 h, and the monolayers were incubated 
with primary antibodies diluted in PBS-0.1% Tween/1% 
BSA at 4 °C overnight (Supplementary Table 1). The 
following day, the primary antibody was removed, and 
the fixed monolayers were washed three times with 
PBS-0.1% Tween/1% BSA. Following this, the cells 
were incubated with the appropriate secondary antibody 
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diluted in PBS/0.1% Tween/1% BSA for 1 h at room 
temperature and washed three times with PBS. Cultures 
were then mounted with PermaFluor aqueous mounting 
medium (Thermo Scientific) and counterstained with 
NucBlue Hoechst 33342 (Sigma-Aldrich). The cells were 
imaged with an Axio Observer Z1 microscope with LD 
PlanNeoFluar objective lenses (Carl Zeiss). This micro-
scope was coupled to a Zeiss AxioCamMR3 camera used 
for image acquisition. The images were captured using a 
Zeiss Axiovision SE 64 Rel 4.8 and analysed using Zeiss 
Axiovision software version 4.9.1.0. The percentage of 
positive cells (±standard deviation) was estimated from 
at least eight random fields of view.
Albumin and α‑fetoprotein ELISA
hESC-derived hepatocyte protein secretion was measured 
by ELISA. Alpha-fetoprotein and albumin production was 
quantified using commercially available kits from Alpha 
Diagnostic International. The different media were col-
lected at the day 18 in the differentiation process. Samples 
were run in duplicate and measured on a FLUOStar Omega 
multi-mode microplate reader (BMG Labtech). Protein pro-
duction was expressed as either nanogram or microgram of 
protein per milliliter of medium per 24 h and per milligram 
of cellular protein [determined by the bicinchoninic acid 
(BCA) assay, Pierce] or as percentage of secretory capac-
ity normalised to the vehicle control. Levels of significance 
were measured by Student’s t test. The experiments are rep-
resentative of five biological replicates.
Cytochrome P450 assays
CYP3A and CYP1A2 activity was measured in hepatocytes 
at Day 18 using pGlo technology (Promega) in accord-
ance with the manufacturer’s instructions. CYP activity 
was expressed as either relative light units (RLUs) per mil-
liliter of medium per milligram of protein (determined by 
the BCA assay, Pierce), or as a percentage of CYP activ-
ity normalised to the vehicle control. Levels of significance 
were measured by Student’s t test. The experiments are rep-
resentative of five biological replicates.
Cell health assays
Cell health was assessed measuring ATP production and 
Caspase 3/7 activity at Day 18 employing pGlo technology 
(Promega) in accordance with the manufacturer’s instruc-
tions. Levels of expression of both markers were expressed 
as percentage of relative light units (RLUs) per milliliter 
of medium and normalised to the vehicle control. Levels of 
significance were measured by Student’s t test. The experi-
ments are representative of five biological replicates.
Detection of smoking derivatives in foetuses 
from smokers and non‑smokers
Cotinine was measured using LC–MS/MS methodology 
as follows. Cotinine and the internal standard 2H3-coti-
nine were dissolved in methanol and diluted in pooled 
human plasma to give calibration standards in the range 
1.5–500 ng/mL. Quality control samples were prepared 
in pooled human plasma at 2.5, 250 and 450 ng/mL coti-
nine. To a 10 µL aliquot of plasma, 10 µL (2 ng) of IS 
was added and 250 µL 0.1% formic acid in water. After 
mixing, the samples were kept on ice for 15 min. Fol-
lowing centrifugation at 14,800 rpm for 15 s, the plasma 
samples were applied to BondElut Plexa PCX cartridges 
(30 mg/1 mL, Crawford Scientific, UK) that had been pre-
conditioned and equilibrated using 0.5 mL of methanol 
and 0.5 mL of 0.1% formic acid in water. The cartridges 
were washed with 0.5 mL 0.1% formic acid in water fol-
lowed by 2 × 0.5 mL 95/5 methanol/0.1% formic acid 
in water and cotinine and the IS eluted with 0.5 mL 95/5 
methanol/ammonium hydroxide. The eluate was evapo-
rated to dryness under nitrogen at room temperature and 
the residue re-suspended in 60 µL 50/50/0.1 water/metha-
nol/formic acid. Following centrifugation at 14,800 rpm 
for 5 min, 5 µL of the supernatant was injected onto the 
chromatograph. Chromatography was performed on a 
Thermo Surveyor (Thermo Scientific, UK) system using 
a 150 × 2.1 mm ACE 3µ C18-AR column (Hichrom, 
UK) maintained at 50 °C. The mobile phase consisted of 
0.1% ammonium acetate (A) and methanol (B) and elu-
tion achieved with a linear gradient over 3 min from 10 
to 100% B with a hold of 1 min at 100% B. The flow rate 
was 200 µL/min and the samples were maintained at 4 °C 
in the autosampler. Total run time was 8 min. A Thermo 
TSQ Quantum triple quadrupole mass spectrometer was 
used in positive electrospray ionisation mode for the detec-
tion of cotinine. Quantification was performed using single 
reaction monitoring (SRM) scan mode using the following 
transitions: cotinine m/z 177.0–80.1 and 2H3-cotinine m/z 
180.0–80.1. Flow injection analysis was used to optimise 
the MS/MS conditions as follows: spray voltage 4000 V, 
sheath gas pressure 60, auxiliary gas pressure 0, capil-
lary temperature 375 °C, skimmer offset −10 V, collision 
pressure 1.7 mTorr and collision energy 25 V. Instrument 
control and peak integration and quantification were per-
formed using Thermo Xcalibur software (v. 2.0.7 SP1). 
Weighted least squares linear regression with a weight-
ing factor of 1/X was used to quantify the cotinine con-
centration in unknown samples by comparing peak area 
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ratios (analyte/IS) with those obtained from a multi-level 
calibration standard curve. PAHs in human foetal livers 
were quantified in Fowler et al. (2014) and the results pre-
sented here in are in different format for display purposes. 
The collection of foetal material (Fowler et al. 2008) 
was approved by the National Health Service Grampian 
Research Ethics Committees (REC 04/S0802/21).
Cell count
Following compound exposure, cells were washed with 
100 μL/well of 1×HBSS (Invitrogen) and fixed with 
50 μL of 4% (wt/vol) paraformaldehyde (PFA) for 
20 min at room temperature. Cells were permeabilized 
with 50 μL/well of 0.1% (vol/vol) Triton X-100 (Sigma-
Aldrich for 15 min), followed by a wash with 100 μL/
well of 1×HBSS and an incubation with 50 μL/well 
of a solution containing 2 drops/mL of NucBlue Live 
 ReadyProbes® Reagent (Molecular Probes) in 1×HBSS 
for 5 min at room temperature. Following incubation, a 
final wash of 100 μL/well of 1×HBSS was performed. 
Fluorescent images were acquired using the Operetta 
high content analysis system with the Harmony High-
Content Imaging and Analysis Software (PerkinElmer). 
20 fields of view were acquired across the well to obtain 
an average representation of the well. Nuclei were 
quantified using the Acapella Image Analysis software 
(PerkinElmer, version: 4.1.1.118082™). The experiments 
are representative of five biological replicates.
Statistical analysis
Unless indicated, all data were obtained from at least five 
biological replicates and are presented by Mean ± standard 
deviation (SD). The difference between control and treat-
ment groups were tested by Student’s t test where P < 0.05 
is denoted as *, P < 0.01 is denoted as ** and P < 0.001 is 
denoted as ***.
Results
Measuring foetal exposure to smoking‑derived 
contaminants
The active components of cigarette smoke are well known 
(Rodgman et al. 2009) and for the purposes of these experi-
ments we focused on cotinine, the major bioactive metabo-
lite of nicotine, and polycyclic aromatic carbons (PAHs). 
Both cotinine and PAHs are significantly increased in the 
foetus by maternal smoking (Fig. 1). Following previous 
in vivo experimentation, we therefore hypothesised that 
these compounds represent a threat to the normal develop-
ment of the foetal liver and we wished to model this in vitro 
Fig. 1  Concentrations of cigarette smoke derivates in the second tri-
mester human foetus. a Polycyclic aromatic hydrocarbons (PAHs) in 
livers from 10 control and 12 smoke-exposed human foetuses. PAHs 
in human foetal livers were quantified in Fowler et al. (2014) and the 
results presented here are in different format for display purposes. b 
The predominant bioactive metabolite of nicotine, cotinine, in plasma 
from 16 control and 22 smoke-exposed foetuses
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using a reliable developmental model. To test this, we gen-
erated hepatoblasts and hepatocytes from male and female 
human embryonic stem cells (hESCs) using established 
methodology (Cameron et al. 2015).
Generation of hepatoblasts and hepatocytes from male 
and female human embryonic stem cells
Both hepatoblasts and hepatocytes were produced at 
scale from hESCs using a stagewise process (Cameron 
et al. 2015) to generate highly pure populations (Fig. 2a). 
During cellular differentiation, cells from both genders 
underwent similar morphological changes, culminating in 
typical hexagonal hepatocyte morphology (Fig. 2b). Fur-
ther characterisation of the hepatocyte populations dem-
onstrated that albumin was expressed in 93% of female 
and 95% of male hepatocytes. In these populations 
HNF4α was detected in 87 and 85% of female and male 
hepatocytes. To determine if hepatocytes were polarised 
we examined E-Cadherin and Zonal Occludin1 (ZO-1) 
expression. E-Cadherin was expressed in 97 and 98% of 
female and male cells, whereas ZO-1 expression detect-
able in 99 and 98% of female and male cells, respectively 
(Fig. 2c).
Fig. 2  Characterisation stem cell derived hepatocytes. a Male 
and female human embryonic stem cells (hESC) were differenti-
ated to hepatocytes employing a stepwise hepatocyte differentiation 
approach. b During differentiation, cells adopted different morpholo-
gies at each stage: definitive endoderm, hepatoblasts and hepatocytes. 
c Immunofluorescence was employed to examine the expression of 
the hepatocyte proteins HNF4α (red) and albumin (green), and epi-
thelial markers E-cadherin (green) and Zona Occludens-1 (green). 
Morphological images were taken at ×10 magnification and scale bar 
represents 200 μm. For each condition eight random fields of view, 
containing at least 400 cells, were counted
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Generation of functional hepatocytes from male 
and female human embryonic stem cells
Following basic characterisation of morphology and gene 
expression, hepatocyte metabolic and secretory capacity 
was studied using pGlo™ and ELISA technologies. Hepat-
ocytes from both sexes demonstrated appreciable levels of 
CYP1A2 and CYP3A activity (Fig. 3a, b). Cytochrome 
P450 activity was greater in female hepatocytes and aligned 
with a previous study (Villarin et al. 2015). Following this, 
albumin (ALB) and alpha-fetoprotein (AFP) secretion were 
measured. Female hepatocytes secreted 4.8 μg/mL/mg pro-
tein of ALB and 10.9 μg/mL/mg protein of AFP (Fig. 3c, 
d), whereas male hepatocytes secreted 2.1 μg/mL/mg 
protein of ALB and 2 μg/mL/mg protein of AFP (Fig. 3c, 
d). These experiments demonstrated that male and female 
hepatocytes displayed dependable performance and were 
suitable for the subsequent modelling experiments.
Determining the sex differences in hepatocyte biology 
following exposure to cotinine and PAHs
Hepatocyte specification and maturation was performed in 
male and female hESCs lines in the presence or absence to 
smoking components. Cotinine at a concentration range of 
1 to 300 nM, chrysene at a concentration range of 10 nM 
to 50 μM, fluorene at a concentration range of 10 nM to 
100 μM, naphthalene at a concentration range of 10nm 
to 1 mM and phenanthrene, at a concentration range of 
10 nM to 500 μM were used. Following 8 days exposure, 
cell health was determined by ATP production and caspase 
activity. Following this cell function was determined meas-
uring CYP P450 3A and 1A2 activity. In order to measure 
the effectiveness of each component of cigarette smoke to 
inhibiting activity we used the half maximal inhibitory con-
centration  (IC50).
Analysis of ATP levels revealed that, independent of 
the sex, the majority of smoking derivatives tested did 
not deplete ATP levels below 50%. The exception was 
phenanthrene, which reduced male ATP levels by 50% at 
78 μM. Cell health was also studied by measuring cas-
pase 3/7 activation in hepatocytes (Table 1; Supplemen-
tary Fig. 1 and 2). In these experiments we observed a 
sex-dependent response in caspase activation. While male 
and female hepatocytes were equally sensitive to conti-
nine, male hepatocytes were more sensitive to chrysene, 
fluorene and phenanthrene, whereas female hepatocytes 
were more sensitive to naphthalene. Subsequently, we 
studied the  IC50 for CYP P450 following exposure to 
smoking derivatives (Table 1; Supplementary Fig. 1 and 
Fig. 3  Stem cell derived hepatocytes display hepatocyte functions. 
Male and female hESCs derived hepatocytes were functionally char-
acterised employing. a, b pGLO™ technology to study cytochrome 
p450 CYP3A and CYP1A2 function. c, d ELISA to measure the 
secretion of hepatocyte proteins albumin and alpha-fetoprotein. Lev-
els of significance were measured by Student’s t test. The experi-
ments are representative of five biological replicates
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2). Loss of CYP1A2 function was more pronounced 
in female hepatocytes following exposure to cotinine, 
chrysene and phenanthrene whereas male hepatocytes 
were more sensitive to fluorene. Of note, naphthalene 
did not reduce CYP P450 activity but, instead, induced 
CYP1A2 activity in male and female hepatocytes 
(Table 1). Analysis of the CYP3A function in response 
to the smoking derivatives also showed sex differences. 
Both male and female hepatocytes responded in a simi-
lar fashion to cotinine, whereas male hepatocyte func-
tion was more sensitive to chrysene, fluorene and naph-
thalene than female hepatocytes. Both male and female 
hepatocytes responded in a similar fashion to cotinine, 
whereas loss of male CYP3A function was less sensitive 
to chrysene and more sensitive to fluorene,  naphthalene 
and phenanthrene than female hepatocytes.
Determining the sex differences in hepatocyte function 
following exposure to smoking derivatives
CYP3A is a major phase 1 enzyme family involved in the 
third trimester of human foetal development. To study 
the effect of a cocktail composed of cotinine and PAHs, 
we incubated hepatocytes with these additives at the  IC50 
values for CYP3A calculated in Table 1. Phase contrast 
images of the cells after incubation with the drug cock-
tail revealed morphological deterioration in both sexes 
(Fig. 4a). Descriptively, female hepatocytes lost hallmark 
hepatocyte features and displayed more fibroblast-like 
structures, whereas male hepatocytes exhibited a more 
rounded morphology. Cell function in both hepatocyte 
populations was also studied in detail. CYP3A activity 
was reduced by 54% in female hepatocytes and by 38% 
in male hepatocytes following exposure (Fig. 4b). This 
was in contrast to CYP1A2 activity which was reduced to 
similar extents in female and male hepatocytes (Fig. 4c). 
We also studied the effect that compound incubation had 
on protein secretion. In accordance with cell CYP P450 
function, secretion of both ALB and AFP were reduced 
in male and female hepatocytes following exposure to the 
smoking derivatives (Fig. 4d, e).
Determining the sex differences in cell biology 
following exposure to smoking derivatives
In addition to cell function, cell health was studied meas-
uring ATP levels and caspase 3/7 activity. ATP levels were 
reduced to a greater extent in female hepatocytes than 
male hepatocytes (Fig. 5a). Whereas caspase activation 
was greater in female hepatocytes (~twofold increase) 
than male hepatocytes (~1.2 fold) (Fig. 5b). Following 
these experiments we examined the number of hepato-
cytes that remained in culture post exposure. Interest-
ingly, male hepatocytes were depleted by 40%, whereas 
female hepatocytes were depleted by 30%. Taken together 
these data demonstrate that male hepatocytes were more 
likely detaching from the matrix and undergoing necrosis, 
whereas the female hepatocytes were undergoing cell dedi-
fferentiation and apoptosis following expoure.
Discussion
The ability to study the effects of maternal smoking on the 
unborn foetus has traditionally relied on material from elec-
tive terminations, animal models and a variety of cell lines. 
While these approaches have generated highly informative 
datasets, they do suffer from some significant drawbacks 
which include tissue scarcity, individual variability and loss 
of cell phenotype. Therefore, to study of the effects of the 
maternal smoking on human foetal liver development, renew-
able cell based models are required which can be delivered 
from defined genetic backgrounds. Encouragingly, pluripo-
tent stem cell based liver models have proven to be effec-
tive in modelling human liver exposure to drugs in the past 
(Medine et al. 2013; Villarin et al. 2015; Szkolnicka et al. 
2014, 2016). In these studies we have employed pluripotent 
stem cells to produce human hepatoblasts at scale and screen 
for developmental perturbation over an eight day time course.
Table 1  IC50 values of the tested compounds on cell health and cell metabolism
Male and female hepatocytes were exposed to the compounds for 8 days. Cell health was measured by analysing ATP production and Caspase 
3/7 activity. Cell metabolism measured CYP1A2 and CYP3A activity
IC50 ATP Caspase 3/7 peak activity IC50 CYP1A2 IC50 CYP3A
Female Male Female Male Female Male Female Male
Cotinine >300 nM >300 nM 100 nM 100 nM 50 nM 100 nM 50 nM 50 nM
Chrysene >50 μM >50 μM 25 μM 5 μM 4.75 μM 55 μM 5 μM 10 μM
Fluorene >100 μM >100 μM >100 μM 100 μM 50 μM 30 μM 34 μM 25 μM
Naphthalene >1000 μM >1000 μM 50 μM 1000 μM Induced activity Induced activity 700 μM 68 μM
Phenanthrene >500 μM 78 μM >500 μM 10 μM 10 μM >500 μM 300 μM 58 μM
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Cigarettes contain a complex mixture of chemicals. 
These compounds pose a risk to foetal development which 
includes increased risk of intrauterine growth restriction, 
small-for-gestational age and preterm delivery amongst 
others (Perera et al. 1998, 2005a, b; Dejmek et al. 2000). To 
identify the major players for our modelling experiments 
we employed gas chromatography and mass spectrometry 
in foetal plasma and livers to identify specific cigarette 
smoke components. From these experiments we identi-
fied cotinine and four PAHs present in foetal circulation of 
mothers who smoked. We used this information to study 
the effects of those derivatives on hepatocyte differentia-
tion from male and female hESCs. On the whole, exposure 
to the compounds singly did not have a detrimental effect 
Fig. 4  Cell morphology and 
metabolic activity following 
smoking component exposure. 
a Phase contrast images reveal 
a deterioration in the cell 
morphology in the presence 
of the mixture of drugs for 
8 days compared with cells 
in the presence of the vehicle 
control. b, c pGLO™ technol-
ogy was employed to measure 
cytochrome P450 activity. d, e 
ELISA was employed to study 
the secretion of albumin and 
alpha-fetoprotein. The images 
were taken at ×10 magnifica-
tion and scale bar represents 
200 μm. Levels of significance 
were measured by Student’s 
t test. The experiments are 
representative of five biological 
replicates
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on hepatocyte biology, but in combination they displayed 
a more marked effect. Following exposure, female hepato-
cytes displayed greater cell number, induced caspase 3/7 
activity and lower ATP levels than male hepatocytes. This 
suggested that female hepatocytes were likely undergo-
ing apoptosis during cell dedifferentiation. Whereas, male 
hepatocytes appeared to be necrotic as they detached from 
the extracellular matrix. Whether these observations are a 
consequence of different levels of metabolic enzyme func-
tion in the hepatocyte populations, or the effects manifest 
due to other sex-dependent processes, will be the study of 
future experimentation.
The sex differences reported in these studies are con-
sistent with previous studies on maternal smoking on 
foetal development. Recently, Filis et al. demonstrated 
that in male foetuses maternal smoking affected path-
ways regulating liver fibrosis and cirrhosis, whereas in 
female foetuses glucose metabolism was more affected 
(Filis et al. 2015). Sex-specific responses to maternal 
smoking is also reflected in the balance of foetal endo-
crine signals (O’Shaughnessy et al. 2007, 2011) and in 
the development of other organs, including the gonads 
(O’Shaughnessy et al. 2007; Fowler et al. 2014; Drake 
et al. 2015) and the placenta (Gabory et al. 2013). While 
sexual dimorphism exists in the expression of these path-
ways, there are also studies which indicate sex-independ-
ent responses leading to disease in the adult (Allina et al. 
2011).
Fig. 5  Measurement of the cell health in female and male hepato-
cytes following exposure to cocktail for 8 days. a Cell viability 
was studied by measuring the levels of ATP. b Cell apoptosis was 
measured using Caspase 3/7 activity. c Cell paint technology was 
employed to analyse the number of cells attached to the matrix
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In summary, our approach has shown that pluripotent 
stem cell derived hepatoblasts and hepatocytes represent 
a useful tool to model foetal liver biology ‘in the dish’, 
providing valuable information on sex differences that 
occur following exposure to components of cigarette 
smoke.
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